Skip to main content
Log in

Follow-up of 151 patients with high-titer U1RNP antibodies

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We performed a longitudinal follow-up study of clinical findings in 151 patients with high-titer antibodies against U1 ribonucleoprotein (U1RNP) as measured by haemagglutination. Formal connective tissue disease (CTD) diagnoses were assigned and diagnostic transitions analysed.

One-hundred eighteen females and 33 males entered the study; the mean duration of follow-up was 7.1 years. Mean age at entry was 34.7 years; 73% of the patients had early disease (duration <2 years). Fifty-six patients (37%) presented with a definite diagnosis, most often mixed connective tissue disease (MCTD, n=40), followed by systemic lupus erythematosus (SLE, n=11) and systemic sclerosis (SSc, n=5). Of 84 patients (56%) presenting with nonspecific symptoms of possible, “undifferentiated” CTD, 58 developed MCTD, 4 SSc and 2 SLE. By the end of the follow-up period, 127 patients had developed a well-defined CTD; final diagnoses were: MCTD (n=97), SLE (n=18), SSc (n=12).

We conclude that CTD in the context of high-titer anti-U1RNP antibodies may be transitive and sequential in nature, although the diagnostic criteria for MCTD previously proposed by our group seem to delimit a clinically stable condition in most patients in this subgroup.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G., Holman, H.R. Mixed connective tissue disease — an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52, 148–159.

    PubMed  Google Scholar 

  2. Bennett, R.M. Scleroderma overlap syndromes. Rheum Dis Clin North Am 1990, 16, 185–198.

    PubMed  Google Scholar 

  3. Bennett, R.M. Mixed connective tissue disease and other overlap syndromes. In: Textbook of Rheumatology, 3rd ed., Eds.: Kelley, W.N., Harris, E.D. Jr., Ruddy, S., Sledge, C.B., Philadelphia, Saunders, 1989, 1147–1165.

    Google Scholar 

  4. Sharp, G.C., Irvin, W.S., May, C.M., Holman, H.R., McDuffie, F.C., Hess, E.V., Schmid, F.R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976, 295, 1149–1154.

    PubMed  Google Scholar 

  5. Grennan, D.M., Bunn, C., Hughes, G.R.V., Buchanan, W.W., Dick, W.C. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups. Ann Rheum Dis 1977, 36, 442–447.

    PubMed  Google Scholar 

  6. Maddison, P.J., Mogavero, H., Reichlin, M. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein. J Rheumatol 1978, 5, 407–411.

    PubMed  Google Scholar 

  7. Gaudreau, A., Amor, B., Kahn, M. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). Ann Rheum Dis 1978, 37, 321–327.

    PubMed  Google Scholar 

  8. Bennett, R.M., O'Connell, D.J. Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980, 10, 25–51.

    PubMed  Google Scholar 

  9. Grant, K.D., Adams, L.E., Hess, E.V. Mixed connective tissue disease — a subset with sequential clinical and laboratory features. J Rheumatol 1981, 8, 587–598.

    PubMed  Google Scholar 

  10. Hochberg, M.C., Dorsch, C.A., Feinglass, E.J., Stevens, M.B. Survivorship in systemic lupus erythematosus: effect of antibody to extractable nuclear antigen. Arthritis Rheum 1981, 24, 54–59.

    PubMed  Google Scholar 

  11. Lemmer, J.P., Curry, N.H., Mallory, J.H., Waller, M.V. Clinical characteristics and course in patients with high titer anti-RNP antibodies. J Rheumatol 1982, 9, 536–542.

    PubMed  Google Scholar 

  12. Leibfarth, J.H., Persellin, R.H. Characteristics of patients with serum antibodies to extractable nuclear antigens. Arthritis Rheum 1976, 19, 851–856.

    PubMed  Google Scholar 

  13. Rasmussen, E.K., Ullman, S., Høier-Madsen, M., Sørensen, S.F., Halberg, P. Clinical implications of ribonucleoprotein antibody. Arch Dermatol 1987, 123, 601–605.

    PubMed  Google Scholar 

  14. Calderon, J., Rodriguez-Valverde, V., Sanchez Andrade, S., Riestra, J.L., Gomez-Reyno, J. Clinical profiles of patients with antibodies to nuclear ribonucleoprotein. Clin Rheumatol 1984, 3, 483–492.

    PubMed  Google Scholar 

  15. Combe, B., Rucheton, M., Graafland, H., Lussiez, V., Brunel, C., Sany, J. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 1989, 75, 18–24.

    PubMed  Google Scholar 

  16. Lundberg, I., Nyman, U., Pettersson, I., Hedfors, E. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 1992, 31, 811–817.

    PubMed  Google Scholar 

  17. Nimelstein, S.H., Brody, S., McShane, D., Holman, H.R. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 1980, 59, 239–248.

    PubMed  Google Scholar 

  18. ter Borg, E.J., Groen, H., Horst, G., Limburg, P.C., Wouda, A.A., Kallenberg, C.G. Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus. Semin Arthritis Rheum 1990, 20, 164–173.

    PubMed  Google Scholar 

  19. Reichlin, M., van Venrooij, W.J. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 1991, 83, 286–290.

    PubMed  Google Scholar 

  20. De Clerck, L.S., Meijers, K.A., Cats, A. Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients. Clin Rheumatol 1989, 8, 29–36.

    PubMed  Google Scholar 

  21. Lundberg, I., Hedfors, E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. J Rheumatol 1991, 18, 1511–1519.

    PubMed  Google Scholar 

  22. Sullivan, W.D., Hurst, D.J., Harmon, C.E., Esther, J.H., Agia, G.A., Maltby, J.D., Lillard, S.B., Held, C.N., Wolfe, J.F., Sunderrajan, E.V., Maricq, H.R., Sharp, G.C. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984, 63, 92–107.

    PubMed  Google Scholar 

  23. Tiddens, H.A., van der Net, J.J., de Graeff Meeder, E.R., Fiselier, T.J., de Rooij, D.J., van Luijk, W.H., Herzberger, R., van Suijlekom, L.W., van Venrooij, W.J., Zegers, B.J., et al, Juvenile-onset mixed connective tissue disease: longitudinal follow-up. J Pediatr 1993, 122, 191–197.

    PubMed  Google Scholar 

  24. Tan, E.M., Cohen, A.S., Fries, J.F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.

    PubMed  Google Scholar 

  25. Masi, A.T., Rodnan, G.P., Medsger, T.A. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Bull Rheum Dis 1981, 31, 1–6.

    PubMed  Google Scholar 

  26. Bohan, A., Peter, J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292, 344–347.

    PubMed  Google Scholar 

  27. Høier-Madsen, M., Andersen, M.G. Microhaemagglutinationstest til undersøgelse for antistoffer mod extractable nuclear antigen (ENA). Ugeskr Laeger 1980, 142, 2627–2630.

    PubMed  Google Scholar 

  28. Sharp, G.C., Irvin, W.S., LaRoque, R.L., Velez, C., Kaiser, A.D., Holman, H.R. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 1971, 50, 350–359.

    PubMed  Google Scholar 

  29. Alarcon-Segovia, D., Villareal, M. Classification and diagnostic criteria for mixed connective tissue disease. In: Mixed Connective Tissue Disease and Anti-nuclear Antibodies. Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Tokyo, 29–30 August 1986, Eds.: Kasukawa, R., Sharp, G.C., Amsterdam, Elsevier, 1987, 33–40.

    Google Scholar 

  30. Sharp, G.C. Diagnostic criteria for classification of MCTD. In: Mixed Connective Tissue Disease and Anti-nuclear Antibodies. Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Tokyo, 29–30 August 1986, Eds.: Kasukawa, R., Sharp, G.C., Amsterdam, Elsevier, 1987, 23–32.

    Google Scholar 

  31. Kasukawa, R., Tojo, T., Miyawaki, S., Yoshida, H., Tanimoto, K., Nobunaga, M., Suzuki, T., Takasaki, Y., Tamura, T. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Mixed Connective Tissue Disease and Anti-nuclear Antibodies. Proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Tokyo, 29–30 August 1986, Eds.: Kasukawa, R., Sharp, G.C., Amsterdam, Elsevier, 1987, 41–47.

    Google Scholar 

  32. Black, C., Isenberg, D.A. Mixed connective tissue disease-goodbye to all that. Br J Rheumatol 1992, 31, 695–700.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frandsen, P.B., Kriegbaum, N.J., Ullman, S. et al. Follow-up of 151 patients with high-titer U1RNP antibodies. Clin Rheumatol 15, 254–260 (1996). https://doi.org/10.1007/BF02229703

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02229703

Key words

Navigation